Cachet Pharmaceutical Hits Day Low at CNY 12.65 Amid Price Pressure

Cachet Pharmaceutical Co., Ltd. experienced a significant decline in its stock performance today, with shares dropping by 7.21% to reach an intraday low of CNY 12.65. This downturn is part of a broader trend, as the stock has underperformed the China Shanghai Composite index, which fell by 1.7% on the same day. Over the past week, Cachet's stock has decreased by 8.93%, and its performance over the last month shows a decline of 8.15%. Year-to-date, the stock is down 11.28%, contrasting sharply with the slight decline of 0.24% in the broader market. The company's long-term growth metrics reveal a concerning trend, with net sales declining at an annual rate of 2.49% and operating profit decreasing by 19.21% over the last five years. Despite being net-debt free, Cachet's return on equity stands at a modest 1.78%, indicating challenges in profitability. The company's inventory turnover ratio is at its lowest, and raw material costs have risen by 15.38% year-over-year. As Cachet Pharmaceutical navigates these financial dynamics, its market position remains under scrutiny.